Parenteral Drugs

PDPL21 Aug 2023
Pharmaceuticals
0.00 (0.00%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Parenteral Drugs
Parenteral Drugs
Pharmaceuticals
PDPL21 Aug 2023
0.00 (0.00%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Parenteral Drugs - Share Price & Details

Lowest Today
2.7
Highest Today
2.9
Today’s Open
2.7
Prev. Close
2.9
52 Week High
3.4
52 Week Low
2.7
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
-14.71%
Upper Circuit
Lower Circuit
P/E TTM
0
P/B Ratio
-0.01
Traded Value(Cr)
0.00
EPS TTM
0
Book value
Dividend
0.00%

Price Performance

0.00 %
1 Wk
-3.33 %
1 M
-3.33 %
3 M
-14.71 %
1 Y
-24.68 %
YTD

Traded Volume Movement

Technical Details

Support 3
3
Support 2
3
Support 1
3
Pivot Point :
3
Resistance 1
3
Resistance 2
4
Resistance 3
4

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Parenteral Drugs (India) Ltd
₹2.90(0.00/0.00%)
2.90+0.008.65-14.710.00-0.01
Lupin Ltd
₹1,597.75(+17.75/1.12%)
1,597.75+17.7572,008.52125.0634.943.74
J B Chemicals & Pharmaceuticals Ltd
₹1,862.90(+38.35/2.10%)
1,862.90+38.3528,316.0774.4055.9310.55
Ipca Laboratories Ltd
₹1,328.25(-19.00/-1.41%)
1,328.25-19.0034,180.3063.0162.095.51
Sanofi India Ltd
₹8,171.55(-12.75/-0.16%)
8,171.55-12.7518,848.4436.6431.8718.53
401.55-0.402,359.671.2913.661.48

About Parenteral Drugs (India) Ltd

Parenteral Drugs (India) Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 10.11 crores. It has reported a sales of Rs. 1.77 crores and a net profit of Rs. 23.81 crores for the quarter ended December 2018. The company management includes Manoharlal Gupta, Manoharlal Gupta,Govind Das Garg,Dharam Pal Khanna,Dilip Kumar Sinha,Anil Mittal,Manish Verma,Vinod Kumar Gupta,Deepali Garhewal,Chhaya Gupta (Parenteral Drugs (India) Ltd) among others.
Chairman
Manoharlal Gupta
Registered office
340 Laxmi Plaza Laxmi Indl Est,New Link Road Andheri (West),Mumbai,Maharashtra,400053
FAX :91-022-26333763
Background
Incorporation Year1983
Face Value₹10
Market Lot1

Latest News

📢 Sensex plunges 213 points at the open; Nifty below 22,350
📈 Amid weak global cues, domestic benchmark indices started gap-down on April 25.
📢 At 9:16 AM, the Sensex tanked 212.95 points or 0.29% at 73,639.99, and the Nifty plunged 63.20 points or 0.28% at 22,339.20.
📊 Kotak Mahindra Bank (⬇️9.27%), LTIM (⬇️2.13%) and HUL (⬇️0.97%) appeared as the top losers on the Nifty 50 at the Open.
25 Apr 2024 | 09:24 AM
📢 Sensex plunges 213 points at the open; Nifty below 22,350
📈 Amid weak global cues, domestic benchmark indices started gap-down on April 25.
📢 At 9:16 AM, the Sensex tanked 212.95 points or 0.29% at 73,639.99, and the Nifty plunged 63.20 points or 0.28% at 22,339.20.
📊 Kotak Mahindra Bank (⬇️9.27%), LTIM (⬇️2.13%) and HUL (⬇️0.97%) appeared as the top losers on the Nifty 50 at the Open.
25 Apr 2024 | 09:24 AM
Multibagger Inox Wind share price rises 5% as Board of Directors propose
Multibagger Inox Wind share price gained more than 5% on Thursday as company's Board of Directors proposed issuance of bonus shares of 3:1. Inox Wind in its release on the exchanges said that “Board of Directors of the company at its meeting held on 25th April 2024 has proposed the issuance of bonus shares of 3:1 (three bonus equity shares for every one existing equity share).
25 Apr 2024 | 02:20 PM
Improved US biotech funding to aid FY25 growth, expects Jonathan Hunt
Syngene International  share price have remained volatile in the recent past. The concerns on challenging funding conditions for US biotech that led to decreased demand for R&D services have addded to the volatility in Biocon Research arm Syngene International share prices. Jonathan Hunt, Managing Director and Chief Executive Officer, Syngene International Limited, said.
25 Apr 2024 | 02:14 PM
Tech Mahindra Q4 result preview: Profit, revenue may shrink YoY
Tech Mahindra Q4 result preview: Tech Mahindra is all set to declare its March quarter result on Thursday, April 25. The IT firm's revenue growth may remain muted, and profit numbers could fall year-on-year. However, Tech Mahindra is expected to report a sequential rise in profit numbers due to the low base of the last quarter. The IT player had reported a 61% year-on-year fall in net profit.
25 Apr 2024 | 02:12 PM

How to buy Parenteral Drugs shares on nse?

To buy Parenteral Drugs shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Parenteral Drugs share price today?

The Parenteral Drugs shares price on nse is Rs.2.9 today.

What is the market cap of Parenteral Drugs shares on NSE ?

The company has a market capitalization of Rs.8.65Cr

What is the PE & PB ratio of Parenteral Drugs shares ?

PE is 0 and PB is -0.01

What is the 52 Week High and Low of Parenteral Drugs shares?

Parenteral Drugs stock price high: Rs.3.4 Parenteral Drugs stock price low: Rs.2.7